Approving J&J’s new depression drug would be an unusual move for the FDA
The Food and Drug Administration would be making an unusual move if it greenlights Johnson & Johnson’s experimental depression treatment,…
Read more
Merck kidney cancer data impresses, putting pressure on Bristol-Myers
Better-than-expected positive results from a late-stage study could position Merck & Co’s immunotherapy Keytruda to play a large role in…
Stem cell transplant slows down MS progression
A preliminary clinical trial shows that stem cell transplantation, along with a tolerable dose of chemotherapy, is safe and more…
Orion and Bayer jointly present new data in prostate cancer from the Darolutamide ARAMIS -study
First presentation of data from the pivotal Phase III ARAMIS trial with the investigational compound darolutamide in patients with advanced…
Sharp enhances IRT solution with latest investment
Sharp – part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has announced a…
From Patient-Centric Technologies to Clinical Trial Supply Chain Management, CRF Bracket Moves Clinical Trials Forward at the 10th Annual SCOPE Summit
Subject matter experts from CRF Bracket take an active thought-leadership role with key presentations and interactive roundtables at the conference…
Development progress in 2018 for acute ischemic stroke drugs will fuel market growth, says GlobalData
Activase (alteplase) is currently the only FDA-approved drug available for the treatment of acute ischemic stroke (AIS) in the 8MM*;…
Brand new type of cancer drug has potential to fill unmet needs in oncology market, says GlobalData
Following a study published in The Lancet Oncology regarding a brand new type of cancer drug that has shown promise…
Despite recent setbacks, the ophthalmology market still offers vast potential, says GlobalData
Despite the ophthalmology market experiencing several research and development (R&D) setbacks during 2018, the launch of three new drugs highlights…
A preliminary clinical trial shows that stem cell transplantation, along with a tolerable dose of chemotherapy, is safe and more effective at slowing down multiple sclerosis than other existing therapies.
Scientists were able to slow down MS progression in a new clinical trial using stem cell transplantation. Multiple sclerosis (MS) is…